An underground market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Investigational Drug Acquiring Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts directly for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Separately, a robust market exists on Telegram, where communities with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could lead to individuals injecting products of unknown origin.
Some experts stated the demand for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.
Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.
Platform Reaction and Content Elimination
Based on TikTok, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The company said it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.
Online Marketplace Operations
Investigations also found communities with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, glowing reviews and detailed guides for mixing or injecting at home.
Within minutes of joining one community, a seller posted contact information, where most purchases occur. The vendor sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or previous experience.
Item Details and Costs
Within these groups, posts display dark colored packages with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A representative for the messaging service stated it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they cannot confirm. Even if the research behind this drug is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to potentially serious health risks”.
